To stay up to date on this litigation, sign up for GLP-1 lawsuit updates to be delivered directly to your inbox.
A similar pattern was observed in the SURMOUNT-4 trial for tirzepatide: after participants lost an average of 20.9% of their body weight during a 36-week lead-in phase, those who stopped treatment regained about 14%, while those who continued taking tirzepatide lost an additional 5.5% over the next year
CP Serum, Super CP Serum or SuperCop 2x, or simply apply them at different times of day
And even now, being off the medication for almost a year, Im still having a lot of problems, she said
Youve heard of GLP-1 medications, but youre hesitant to try them due to the side effects
As one expert explains, operating on someone still actively losing weight is like aiming at a moving target. Your final results depend on having a stable foundation